Gozal David, Farré Ramon, Nieto F Javier
Department of Pediatrics, Pritzker School of Medicine, Biological Sciences Division, The University of Chicago, Chicago, IL.
Unitat de Biofísica i Bioenginyeria, Facultat de Medicina, Universitat de Barcelona-IDIBAPS, Barcelona, Spain; CIBER de Enfermedades Respiratorias, Bunyola, Spain.
Chest. 2015 Nov;148(5):1140-1147. doi: 10.1378/chest.15-0634.
In recent years, the potentially adverse role of sleep-disordered breathing in cancer incidence and outcomes has emerged. In parallel, animal models of intermittent hypoxia (IH) and sleep fragmentation (SF) emulating the two major components of OSA have lent support to the notion that OSA may enhance the proliferative and invasive properties of solid tumors. Based on several lines of evidence, we propose that OSA-induced increases in sympathetic outflow and alterations in immune function are critically involved in modifying oncologic processes including angiogenesis. In this context, we suggest that OSA, via IH (and potentially SF), promotes changes in several signaling pathways and transcription factors that coordinate malignant transformation and expansion, disrupts host immunologic surveillance, and consequently leads to increased probability of oncogenesis, accelerated tumor proliferation, and invasion, ultimately resulting in adverse outcomes.
近年来,睡眠呼吸紊乱在癌症发生和预后方面的潜在不利作用已显现出来。与此同时,模拟阻塞性睡眠呼吸暂停(OSA)两大主要成分的间歇性缺氧(IH)和睡眠片段化(SF)动物模型,支持了OSA可能增强实体瘤增殖和侵袭特性这一观点。基于多条证据,我们提出,OSA引起的交感神经输出增加和免疫功能改变在包括血管生成在内的肿瘤过程改变中起关键作用。在此背景下,我们认为,OSA通过IH(以及可能的SF)促进了协调恶性转化和扩展的多种信号通路和转录因子的变化,破坏了宿主免疫监视,从而导致肿瘤发生概率增加、肿瘤增殖加速和侵袭,最终导致不良预后。